Wilder
发表于 2025-3-21 18:09:16
书目名称Contemporary Bone Marrow Transplantation影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0236370<br><br> <br><br>书目名称Contemporary Bone Marrow Transplantation影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0236370<br><br> <br><br>书目名称Contemporary Bone Marrow Transplantation网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0236370<br><br> <br><br>书目名称Contemporary Bone Marrow Transplantation网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0236370<br><br> <br><br>书目名称Contemporary Bone Marrow Transplantation被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0236370<br><br> <br><br>书目名称Contemporary Bone Marrow Transplantation被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0236370<br><br> <br><br>书目名称Contemporary Bone Marrow Transplantation年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0236370<br><br> <br><br>书目名称Contemporary Bone Marrow Transplantation年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0236370<br><br> <br><br>书目名称Contemporary Bone Marrow Transplantation读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0236370<br><br> <br><br>书目名称Contemporary Bone Marrow Transplantation读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0236370<br><br> <br><br>
祝贺
发表于 2025-3-21 20:30:21
http://reply.papertrans.cn/24/2364/236370/236370_2.png
OATH
发表于 2025-3-22 01:11:42
http://reply.papertrans.cn/24/2364/236370/236370_3.png
不公开
发表于 2025-3-22 05:01:43
http://reply.papertrans.cn/24/2364/236370/236370_4.png
严厉批评
发表于 2025-3-22 10:30:24
Chimerism in Hematopoietic Stem Cell Transplantationes in the successful engraftment of the donor stem cells in the host environment. The degree of donor cell component in the recovering hematopoiesis in the host is a critical factor which affects posttransplant immunomodulation, relapse of primary disease, posttransplant complications, and ultimatel
EXTOL
发表于 2025-3-22 15:08:01
HSCT in Malignanciesers or solid organ cancer. The better understanding of disease physiopathology and the continuous development of new therapeutic strategies has an incessant impact in HCT indication. In addition, the refinement in HCT techniques and supportive care has remarkable reduced transplant-related mortality
EXTOL
发表于 2025-3-22 19:44:42
http://reply.papertrans.cn/24/2364/236370/236370_7.png
micronutrients
发表于 2025-3-23 00:12:24
Hemopoietic Stem Cell Transplant for Non-hematological Disordersrders is perhaps less obvious since the blood cells themselves function normally and there is no malignancy. The application of HCT in non-hematological disease is a growing area and is likely to concern all transplant physicians in the coming decades..HCT in leukemia is intuitive, even to the lay p
纺织品
发表于 2025-3-23 02:50:36
Allogeneic Transplant Overview and Matched Related Donor Transplantignancies and other malignant and nonmalignant diseases. Since the first allogeneic transplants more than five decades ago, significant advances have occurred in transplantation technology, donor availability, and supportive care that have made transplantation safer and increasingly available to pat
陈旧
发表于 2025-3-23 05:38:57
Haploidentical Transplantation: Challenges and Solutions hematological malignancies. The primary reason for this has been the emergence of posttransplantation cyclophosphamide as graft-versus-host disease (GVHD) prophylaxis, which by dint of both, its ease of application and impressive outcomes, has made HFD-HCT feasible across the globe. Studies have co